Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Questions Remain For Samsung Bioepis Post-Biogen
Management Changes, Strategic Focus And Structural Aspects Yet To Be Decided
Feb 08 2022
•
By
David Wallace
The future path for Samsung Bioepis is not yet fully decided • Source: Cagkan Sayin / Alamy Stock Photo
More from Biosimilars
More from Products